Literature DB >> 4834945

Chemical structure of erythromycin and hepatotoxicity.

K G Tolman, J J Sannella, J W Freston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4834945     DOI： 10.7326/0003-4819-81-1-58

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.

Authors:  N Principi; S Esposito
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

2.  Hepatotoxicity of erythromycin derivatives.

Authors:  D Pessayre; J P Benhamou
Journal:  Br Med J       Date:  1979-05-19

3.  Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases.

Authors:  E S Zafrani; K G Ishak; C Rudzki
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

Review 4.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

5.  Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.

Authors:  E B Keeffe; T C Reis; J E Berland
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

6.  Cross hepatotoxicity between tricyclic antidepressants.

Authors:  D Larrey; B Rueff; D Pessayre; G Danan; M Algard; J Geneve; J P Benhamou
Journal:  Gut       Date:  1986-06       Impact factor: 23.059
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.